Avid Bioservices, Inc, the contract manufacturing subsidiary of Peregrine Pharmaceuticals, Inc. based in Tustin, California, has initiated an expansion of its biomanufacturing capacity. Avid provides clinical and commercial manufacturing services under cGMP for the biotechnology and biopharmaceutical industries. The new production facility will more than double Avid Bioservices’ current manufacturing capacity.

The facility will use a flexible modular cleanroom design and single-use technologies. The capacity expansion will take place within an existing 40,000- square foot warehouse located adjacent to the company’s current campus. The new cGMP facility will accommodate multiple single-use bioreactors of up to 2,000 liters, downstream processing suites, and dedicated support utilities that will allow for the production of a variety of biological products.

Avid’s services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, final product filling, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell-line development and optimization, cell culture and feed optimization, analytical methods development, and product characterization.

Source: Avid Bioservices